American Journal of Physiology-Cell Physiology · 1993 · 90 citations · 18 references
Life SciencesPharmacologyPhysiologyAgingMitochondrial BiologyRenal PathophysiologyAge-related Physiological ChangesAging PhysiologyBiological AgingCardiovascular AgingMitochondrial DysfunctionMitochondrial PhysiologyAge-related PhysiologyHepatic AgingMetabolic Changes In AgingMitochondrial Dysfunction In AgingMorphometric AnalysisMorphometric CharactersPhysiological Changes In Aging
To investigate the effects of angiotensin-converting enzyme (ACE) inhibitors on the cellular function and structure in a variety of organs during the aging process, one hundred CF1 mice were divided into four groups of 25 animals each. Groups A, B, and C received enalapril in drinking water from weaning until the age of 24 mo. Doses administered were (in mg/l): group A, 20; group B, 10; group C, 5. Group D is the control. Animals were killed, and morphometric studies were performed in heart, kidney, liver, and spleen. As a result, there was a decrease of renal and myocardial sclerosis and an increase in the number of mitochondria in heart and liver cells, which is associated with a significant increase in survival of animals receiving ACE inhibitors. These findings lead us to think that natural aging mechanisms have been altered in those animals.
18
Denham Harman · Proceedings of the National Academy of Sciences · 1981 · 1.9K citations · Full text
Life Sciences, Immunology, Nutrition +17
Reversing glomerular hypertension stabilizes established glomerular injury
Timothy W. Meyer, Sharon Anderson, Helmut G. Rennke et al. · Kidney International · 1987 · 271 citations · Full text
Medicine, Nephrology, Physiology +13